Silihan lan utang jangka dawa perusahaan FSD Pharma Inc. (HUGE)

FSD Pharma Inc. (HUGE) focuses on developing high-precision drugs to combat severe inflammation and neuronal degeneration. The market price on the GURU.Markets platform, where long-term debt stands at 0.00, as confirmed by this chart, is complemented by the stability of a tight-knit circle of leading neurobiologists. Business development relies on a strategic alliance with biotech centers to identify new therapeutic approaches in the field of neurology.

HUGE FSD Pharma: Utang jangka dawa perusahaan ing interval 04.07.2022 - 15.08.2024

HUGE (FSD Pharma): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:

Rega saham fsdpharma.com|HUGE - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar FSD Pharma|HUGE - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham FSD Pharma|HUGE - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku fsdpharma.com|HUGE - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi FSD Pharma Inc.|HUGE - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal FSD Pharma, Inc.|HUGE - Gunggung utang perusahaan|Utang-utang marang nilai buku FSD Pharma|HUGE - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan FSD Pharma

Pambiji fundamental:HUGE - fsdpharma.com

The indicator aggregates all confirmed credit obligations with maturities exceeding twelve months. The calculation is based on verified reporting data, excluding subjective estimates. The long-term debt dynamics for FSD Pharma Inc. (HUGE) reflect the actual volume of raised capital. This metric is critical for FSD Pharma Inc. during a shift in R&D focus, as it demonstrates the startup's financial stability during the transition to clinical trials for neurological drugs.

Karo sapa FSD Pharma Inc. saingan